Digestive Health

News Watch

In this interview, filmed during the 4th Gut Microbiota for Health World Summit, Professor Magnus Simrén of the University of Gothenburg (Sweden) and Chairman of the United European Gastroenterology (UEG) Scientific Committee, explains to Gut Microbiota Worldwatch the relationship between the gut microbiota and irritable bowel syndrome (IBS). The video tells us exactly what irritable bowel syndrome is, what kind of…

GMFH Editing Team
GMFH Editing Team

In this interview, filmed during the 4th Gut Microbiota for Health World Summit, Professor Magnus Simrén of the University of Gothenburg (Sweden) and Chairman of the United European Gastroenterology (UEG) Scientific Committee, explains to Gut Microbiota Worldwatch the relationship between the gut microbiota and irritable bowel syndrome (IBS). The video tells us exactly what irritable bowel syndrome is, what kind of…

GMFH Editing Team
GMFH Editing Team

Abdominal pain, bloating, changes in stool frequency and consistency. These are just some of the symptoms associated with Irritable Bowel Syndrome (IBS), a chronic functional disorder whose origins are unknown. It has no known treatment, only recommendations to keep symptoms at bay. In Western countries, almost two out of ten gastroenterology consultations are motivated by this disorder.   Professor Magnus Simrén, researcher at…

GMFH Editing Team
GMFH Editing Team

Abdominal pain, bloating, changes in stool frequency and consistency. These are just some of the symptoms associated with Irritable Bowel Syndrome (IBS), a chronic functional disorder whose origins are unknown. It has no known treatment, only recommendations to keep symptoms at bay. In Western countries, almost two out of ten gastroenterology consultations are motivated by this disorder.   Professor Magnus Simrén, researcher at…

GMFH Editing Team
GMFH Editing Team

Colorectal cancer (also known as bowel cancer) is the third most common cancer in the world, according to World Cancer Research Fund International. By 2035, it is predicted there will be 2.4 million cases of this type of tumour diagnosed annually worldwide, mostly in developed countries. The risk of developing it is about 1 in 20 (5%) and it is…

GMFH Editing Team
GMFH Editing Team

Colorectal cancer (also known as bowel cancer) is the third most common cancer in the world, according to World Cancer Research Fund International. By 2035, it is predicted there will be 2.4 million cases of this type of tumour diagnosed annually worldwide, mostly in developed countries. The risk of developing it is about 1 in 20 (5%) and it is…

GMFH Editing Team
GMFH Editing Team

As we have explained before in this blog, breast milk is one major way in which an infant’s gut microbiota starts developing. We now know that an antibody contained in breast milk provides lifelong protection from illnesses such as the inflammatory bowel disease (IBD), by setting up defences in the gut flora of breastfed babies. These are the main findings…

GMFH Editing Team
GMFH Editing Team

As we have explained before in this blog, breast milk is one major way in which an infant’s gut microbiota starts developing. We now know that an antibody contained in breast milk provides lifelong protection from illnesses such as the inflammatory bowel disease (IBD), by setting up defences in the gut flora of breastfed babies. These are the main findings…

GMFH Editing Team
GMFH Editing Team

Transferring microbes from the colon of a mouse with a colorectal tumour to a healthy mouse means the latter will also develop cancer, according to a study recently published in mBio® by Zackular JP  et al., the open access journal of The American Academy of Microbiology. It was already known that inflammation played an important role in the development of colorectal…

GMFH Editing Team
GMFH Editing Team

Transferring microbes from the colon of a mouse with a colorectal tumour to a healthy mouse means the latter will also develop cancer, according to a study recently published in mBio® by Zackular JP  et al., the open access journal of The American Academy of Microbiology. It was already known that inflammation played an important role in the development of colorectal…

GMFH Editing Team
GMFH Editing Team

Research & Practice

For those seeking the latest science on gut health and its applications to clinical practice, Paris was the place to be on March 11th and 12th, 2017. At the 6th GMFH World Summit, over 400 professionals from all over the world met to review the past decade of advances in gut microbiota science and where the field is headed in…

GMFH Editing Team
GMFH Editing Team

For those seeking the latest science on gut health and its applications to clinical practice, Paris was the place to be on March 11th and 12th, 2017. At the 6th GMFH World Summit, over 400 professionals from all over the world met to review the past decade of advances in gut microbiota science and where the field is headed in…

GMFH Editing Team
GMFH Editing Team

Public awareness about the importance of the gut microbiota is growing, but many nutrition professionals struggle to know how to incorporate findings from gut microbiota science into their practice. In a rapidly-progressing field, what should clinicians know about how gut microbes and diet interact to produce different health outcomes? At the 2017 Gut Microbiota for Health World Summit in Paris…

GMFH Editing Team
GMFH Editing Team

Public awareness about the importance of the gut microbiota is growing, but many nutrition professionals struggle to know how to incorporate findings from gut microbiota science into their practice. In a rapidly-progressing field, what should clinicians know about how gut microbes and diet interact to produce different health outcomes? At the 2017 Gut Microbiota for Health World Summit in Paris…

GMFH Editing Team
GMFH Editing Team

Helicobacter pylori (Hp) chronic infection is increasing worldwide and is involved in the pathogenesis of chronic gastritis, peptic ulcers, and gastric cancer. Eradication of the bacterium through proton-pump inhibitor (PPI)-based triple therapy (PPI, amoxicillin and either clarithromycin or metronidazole and clarithromycin) or bismuth-based quadruple therapy (bismuth added to the standard twice-daily PPI-based triple therapy) has recently decreased, mainly due to…

Paul Enck
Prof. Dr. Paul Enck, Director of Research, Dept. of Psychosomatic Medicine and Psychotherapy, University Hospital Tübingen, Germany. His main interests are gut functions in health and disease, including functional and inflammatory bowel disorders, the role of the gut microbiota, regulation of eating and food intake and its disorders, of nausea, vomiting and motion sickness, and the psychophysiology and neurobiology of the placebo response, with specific emphasis on age and gender contributions. He has published more than 170 original data paper in scientific, peer-reviewed journals, and more than 250 book chapters and review articles. He is board member/treasurer of the European Society of Neurogastroenterology and Motility and of the German Society of Neurogastroenterology and Motility, and has served as reviewer for many international journals and grant agencies.

Helicobacter pylori (Hp) chronic infection is increasing worldwide and is involved in the pathogenesis of chronic gastritis, peptic ulcers, and gastric cancer. Eradication of the bacterium through proton-pump inhibitor (PPI)-based triple therapy (PPI, amoxicillin and either clarithromycin or metronidazole and clarithromycin) or bismuth-based quadruple therapy (bismuth added to the standard twice-daily PPI-based triple therapy) has recently decreased, mainly due to…

Paul Enck
Prof. Dr. Paul Enck, Director of Research, Dept. of Psychosomatic Medicine and Psychotherapy, University Hospital Tübingen, Germany. His main interests are gut functions in health and disease, including functional and inflammatory bowel disorders, the role of the gut microbiota, regulation of eating and food intake and its disorders, of nausea, vomiting and motion sickness, and the psychophysiology and neurobiology of the placebo response, with specific emphasis on age and gender contributions. He has published more than 170 original data paper in scientific, peer-reviewed journals, and more than 250 book chapters and review articles. He is board member/treasurer of the European Society of Neurogastroenterology and Motility and of the German Society of Neurogastroenterology and Motility, and has served as reviewer for many international journals and grant agencies.

Faecal microbiota transplantation (FMT) is currently investigated as a novel treatment option for several chronic diseases related to gut dysbiosis with the strongest evidence for efficacy in the treatment of recurrent Clostridium difficile infection. Although clear reporting of FMT methodology is important to better understand and reproduce studies, reports of the methodological components of FMT interventions in clinical trials vary…

Andreu Prados
Andreu Prados holds a Bachelor of Science Degree in Pharmacy & Human Nutrition and Dietetics. Science writer specialised in gut microbiota and probiotics, working also as lecturer and consultant in nutrition and healthcare. Follow Andreu on Twitter @andreuprados

Faecal microbiota transplantation (FMT) is currently investigated as a novel treatment option for several chronic diseases related to gut dysbiosis with the strongest evidence for efficacy in the treatment of recurrent Clostridium difficile infection. Although clear reporting of FMT methodology is important to better understand and reproduce studies, reports of the methodological components of FMT interventions in clinical trials vary…

Andreu Prados
Andreu Prados holds a Bachelor of Science Degree in Pharmacy & Human Nutrition and Dietetics. Science writer specialised in gut microbiota and probiotics, working also as lecturer and consultant in nutrition and healthcare. Follow Andreu on Twitter @andreuprados

Previous research has shown that the gut microbiome could influence cancer outcomes through its interaction with host immunity. Indeed, mouse studies have shown the anti-cancer effects of chemotherapeutic drugs such as cyclophosphamide and celecoxib could be mediated by commensal species. However, the mechanisms by which gut microbial communities influence response to chemotherapeutic drugs remains poorly understood. Two recent studies using…

Andreu Prados
Andreu Prados holds a Bachelor of Science Degree in Pharmacy & Human Nutrition and Dietetics. Science writer specialised in gut microbiota and probiotics, working also as lecturer and consultant in nutrition and healthcare. Follow Andreu on Twitter @andreuprados

Previous research has shown that the gut microbiome could influence cancer outcomes through its interaction with host immunity. Indeed, mouse studies have shown the anti-cancer effects of chemotherapeutic drugs such as cyclophosphamide and celecoxib could be mediated by commensal species. However, the mechanisms by which gut microbial communities influence response to chemotherapeutic drugs remains poorly understood. Two recent studies using…

Andreu Prados
Andreu Prados holds a Bachelor of Science Degree in Pharmacy & Human Nutrition and Dietetics. Science writer specialised in gut microbiota and probiotics, working also as lecturer and consultant in nutrition and healthcare. Follow Andreu on Twitter @andreuprados